Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study
Junya Kanda(Kyoto University), Takashi Uchiyama(Kyoto University), Koji Nagafuji(Kyushu University), Minoko Takanashi, Atae Utsunomiya(Imamura Hospital), Tatsuo Ichinohe(Kyoto University), Yoshiko Atsuta(Aichi Medical University), Yukiyoshi Moriuchi(Sasebo City General Hospital), Shuichi Taniguchi(Toranomon Hospital), Tokiko Nagamura‐Inoue(Tokyo University of Science), Keitaro Matsuo(Aichi Cancer Center), Tetsuya Eto(Hamanomachi Hospital), Masamichi Hara(Ehime Prefectural Central Hospital), Yasushi Miyazaki(Nagasaki University), Hisashi Sakamaki(Tokyo Metropolitan Komagome Hospital), Fumio Kawano(Kumamoto Medical Center), Ryuji Tanosaki(National Cancer Center), Shunichi Kato(Data Management (Italy)), Takakazu Kawase(Aichi Cancer Center), Yasuo Morishima, Jun Okamura, Shunro Kai(Hyogo Medical University), Ritsuro Suzuki(Nagoya University), Masato Masuda(University of the Ryukyus), Masakatsu Hishizawa(Kyoto University)
Cited by 124
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363
Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
|International Journal of Hematology|2015|352